Norm Rosenthal

发表论文 34 篇 · 总被引 1006 次 · h-index 9

代表论文

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function (2018 · Circulation · 被引 254)
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study (2017 · Diabetes Obesity and Metabolism · 被引 120)
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials (2017 · Diabetes Obesity and Metabolism · 被引 103)
Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis (2020 · Diabetes Obesity and Metabolism · 被引 32)
Renal safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes mellitus (2017 · Diabetes Obesity and Metabolism · 被引 27)
Canagliflozin (CANA) vs. Other Antihyperglycemic Agents on the Risk of Below-Knee Amputation (BKA) for Patients with T2DM—A Real-World Analysis of &gt;700,000 U.S. Patients (2018 · Diabetes · 被引 4)